Feb 12 (Reuters) - Vertex Pharmaceuticals Inc:
* VERTEX PHARMACEUTICALS INC - FDA APPROVED SYMDEKO FOR TREATING UNDERLYING CAUSE OF CYSTIC FIBROSIS IN PEOPLE AGES 12 AND OLDER
* VERTEX PHARMACEUTICALS INC - READY TO LAUNCH SYMDEKO AND WILL BEGIN SHIPPING IT TO PHARMACIES IN UNITED STATES THIS WEEK Source text for Eikon: Further company coverage: